HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

L'Oreal Seeks Monograph Inclusion Of Next-Gen Mexoryl UV Filter

This article was originally published in The Rose Sheet

Executive Summary

L'Oreal has filed to have the second of its organic UV filters - drometrizole trisiloxane, marketed as Mexoryl XL - added to FDA's monograph for over-the-counter sunscreen drug products
Advertisement

Related Content

Most U.S. Sunscreens Not So Hot, Reflecting FDA Failures – EWG
Most U.S. Sunscreens Not So Hot, Reflecting FDA Failures – EWG
EWG’s Sunscreen Recommendations Up From 2010, But Health Concerns Remain
EWG’s Sunscreen Recommendations Up From 2010, But Health Concerns Remain
Environmental Group Assesses Availability Of UVA Protection, Warns Public
Environmental Group Assesses Availability Of UVA Protection, Warns Public
EWG Advises Against Vitamin A Compound, More Than 90% Of Sunscreens
FDA Deems UVA Filter Ecamsule Eligible For Monograph, Seeks Data
FDA Deems UVA Filter Ecamsule Eligible For Monograph, Seeks Data
Advertisement
UsernamePublicRestriction

Register

RS016977

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel